Breaking News Instant updates and real-time market news.

CRWD

Crowdstrike

$58.57

-2.75 (-4.48%)

, TEX

Terex

$24.52

0.7 (2.94%)

10:16
10/11/19
10/11
10:16
10/11/19
10:16

Fly Intel: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Crowdstrike (CRWD) downgraded to Sell from Neutral at Goldman Sachs with analyst Heather Bellini stating while CrowdStrike is very well positioned in the market for endpoint security, a "blue sky analysis" suggests this is likely priced in at current share levels. 2. Terex (TEX) downgraded to Underweight from Equal Weight at Barclays with analyst Adam Seiden expecting the rental equipment market to move from equilibrium to oversupplied by 2020. 3. Delta Air Lines (DAL) downgraded to Hold from Buy at Argus with analyst John Staszark saying that while Delta is among the best managed airlines, he thinks better returns are available elsewhere, as Delta is facing prospects for rising costs and slowing revenue growth. 4. PG&E (PCG) downgraded to Sell from Neutral at Citi with analyst Praful Mehta seeing a 75% chance of the stock going to zero after Judge Montali terminated PG&E's exclusive right to advance a plan of reorganization. 5. Canopy Growth (CGC) downgraded to Underperform from Hold at Jefferies with analyst Owen Bennett saying despite the recent selloff in shares, Canopy is the most expensive name across the cannabis space. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

CRWD

Crowdstrike

$58.57

-2.75 (-4.48%)

TEX

Terex

$24.52

0.7 (2.94%)

DAL

Delta Air Lines

$52.75

-0.35 (-0.66%)

PCG

PG&E

$8.33

0.55 (7.07%)

CGC

Canopy Growth

$20.67

0.245 (1.20%)

  • 10

    Nov

  • 10

    Nov

  • 12

    Nov

  • 12

    Dec

  • 07

    Jan

CRWD Crowdstrike
$58.57

-2.75 (-4.48%)

10/11/19
GSCO
10/11/19
DOWNGRADE
Target $66
GSCO
Sell
Crowdstrike downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst Heather Bellini downgraded Crowdstrike Holdings (CCRWD) to Sell from Neutral with a price target of $66, down from $83. The shares closed Thursday down $1.67 to $61.41. While CrowdStrike is very well positioned in the market for endpoint security, and can continue to post upside to estimates, a "blue sky analysis" suggests this is likely priced in at current share levels, Bellini tells investors in a research note. The analyst this morning also upgraded Workday (WDAY) to Buy from Neutral. Her "Blue Sky analyses" show that the companies with the highest potential upside to 2020 estimates are Zoom Video (ZM), Slack Technologies (WORK), and Elastic (ESTC).
10/08/19
JEFF
10/08/19
INITIATION
Target $67
JEFF
Hold
Crowdstrike assumed with a Hold rating at Jefferies
Jefferies analyst Brent Thill assumed coverage of Crowdstrike with a Hold rating and price target of $67, down from $80. The analyst last night assumed coverage of the Software industry and adjusted some of his ratings to be more defensive in light of valuation and macroeconomic concerns. However, he remains positive on the industry and believes that the fundamentals of businesses in the space are "very strong."
10/03/19
10/03/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Raytheon (RTN) upgraded to Outperform from Neutral at Credit Suisse WITH analyst Robert Spingarn saying he believes United Technologies' (UTX) aerospace businesses are undervalued and that the market has yet to appropriately discount Raytheon's ~43.1% ownership of the proposed combined entity. 2. Wipro (WIT) upgraded to Neutral from Sell at Goldman Sachs with analyst Sumeet Jain citing valuation. 3. Dova Pharmaceuticals (DOVA) upgraded to Neutral from Underweight at JPMorgan with analyst Joel Fishbein saying the company's "strong" execution continues to drive "impressive growth at scale" as customer deal sizes grow amid larger initial deployments and customers adopting multiple products. 4. Crowdstrike (CRWD) upgraded to Buy from Hold at SunTrust with analyst Joel Fishbein saying the company has developed a "category-defining" cloud platform for cyber security, a market that is "ripe for disruption." 5. Newmont Goldcorp (NEM) upgraded to Buy from Hold at Deutsche Bank with analyst Chris Terry saying shares of Newmont have significantly underperformed compared to its closest peer Barrick Gold (GOLD) and also versus the gold price. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/02/19
RHCO
10/02/19
UPGRADE
Target $80
RHCO
Buy
SunTrust upgrades 'category-defining' Crowdstrike to Buy from Hold
SunTrust analyst Joel Fishbein upgraded Crowdstrike to Buy from Hold with an $80 price target after taking over coverage from Terry Tillman. The company has developed a "category-defining" cloud platform for cyber security, a market that is "ripe for disruption," Fishbein tells investors in a research note. While the shares are not inexpensive, there are "several catalysts," including success in trial to pay, deeper penetration in both federal and international markets, and leverage from Crowdstrike's Dell relationship, contends the analyst.
TEX Terex
$24.52

0.7 (2.94%)

09/11/19
JPMS
09/11/19
NO CHANGE
JPMS
In Machinery shift, JPMorgan upgrades Agco and Oshkosh, cuts Actuant
With her U.S. Machinery coverage universe underperforming the broader market year-to-date, but outperforming since Labor Day amid a rotation into cyclicals, JPMorgan analyst Ann Duignan established December 2020 price targets based on where she believes we are in the cycle for end market demand. The analyst sees North America and Europe truck demand at or beyond peak, North America construction equipment "perhaps rolling over" in 2020, North America agriculture equipment demand "likely stagnating" near mid-cycle, and mining equipment "slowly approaching" mid-cycle. Within this framework, Duignan this morning upgraded both Agco (AGCO) and Oshkosh (OSK) to Overweight from Neutral, saying both stocks look undervalued with relatively limited downside risk to earnings estimates. Additionally, the analyst downgraded Actuant (ATU) to Underweight from Neutral, saying the risks appear weighted to the downside at current valuation levels. She sees elevated risk of management overpaying for acquisitions should it pursue the pipeline of potential targets. Duignan also maintained Overweight ratings on Eaton (ETN), Caterpillar (CAT) and Terex (TEX), and Underweight ratings on Deere (DE) and Allison Transmission (ALSN).
10/11/19
LEHM
10/11/19
DOWNGRADE
Target $20
LEHM
Underweight
Barclays downgrades Terex to Underweight on oversupplied rental market
Barclays analyst Adam Seiden downgraded Terex to Underweight from Equal Weight with a price target of $20, down from $33. The analyst expects the rental equipment market to move from equilibrium to oversupplied by 2020. The gap between rental equipment days on rent and days on supply is growing, Seiden tells investors in a research note. With several key rental customers focused on utilization into the downturn, buying less equipment, or at least not more year-over-year, is highly likely, contends the analyst. Seiden also thinks lower equipment demand is likely to weigh on industry aerials pricing for 2020.
10/11/19
LEHM
10/11/19
DOWNGRADE
Target $20
LEHM
Underweight
Terex downgraded to Underweight from Equal Weight at Barclays
Barclays analyst Adam Seiden downgraded Terex to Underweight from Equal Weight with a $20 price target.
10/01/19
BOFA
10/01/19
NO CHANGE
BOFA
Top 10 US Ideas for Q4 at BofA/Merrill
BofA/Merrill introduced the Top 10 US Ideas for Q4 2019. The list's seven Buys are Aramark (ARMK), Salesforce (CRM), Disney (DIS), Dover (DOV), New York Community Bancorp (NYCB), Raytheon (RTN), and Target (TGT). Underperform's are Floor & Decor (FND), Gap (GPS), and Terex (TEX).
DAL Delta Air Lines
$52.75

-0.35 (-0.66%)

10/11/19
ARGS
10/11/19
DOWNGRADE
ARGS
Hold
Delta Air Lines downgraded to Hold from Buy at Argus
10/11/19
RAJA
10/11/19
NO CHANGE
Target $64
RAJA
Outperform
Delta Air Lines price target lowered to $64 from $70 at Raymond James
Raymond James analyst Savanthi Syth lowered her price target for Delta Airlines to $64 from $70 following the company's Q3 results, saying the report underperformed peers due to elevated idiosyncratic costs. Domestic revenue trends appear stable, Syth tells investors in a research note and with elevated costs now factored in, she expects its mid-December investor day to create favorable momentum for shares. Syth reiterated her Outperform rating on the shares due to its attractive valuation, strong balance sheet, and her view that structural advantages will allow Delta to retain its relative operational and financial leadership vs. legacy peers.
10/11/19
ARGS
10/11/19
DOWNGRADE
ARGS
Hold
Delta Air Lines downgraded on higher costs, slower growth at Argus
Argus analyst John Staszark downgraded Delta Air Lines (DAL) to Hold from Buy following the company's Q3 results, saying that while Delta is among the best managed airlines, he thinks better returns are available elsewhere, as Delta is facing prospects for rising costs and slowing revenue growth. He recommends shares of United Continental (UAL) over Delta. Longer term, he expects Delta to benefit from solid industry fundamentals, including moderate capacity growth, growing ancillary revenue, and rising demand for air travel.
10/10/19
SPHN
10/10/19
NO CHANGE
Target $75
SPHN
Overweight
Delta Q4 outlook likely to be 'somewhat disappointing,' says Stephens
Stephens analyst Jack Atkins said Delta Air Lines' Q4 RASM and adjusted EPS outlook is "likely to be somewhat disappointing for investors," who also are frustrated that Delta has raised its unit cost outlook into the end of the year "once again. While he thinks 2020 will likely be more of a challenge for the company given a slower macro backdrop and elevated domestic capacity growth, Atkins is still "favorably biased" toward Delta over the long-term as he sees it as a "best-in-breed" carrier. He keeps an Overweight rating on the stock but his estimates and $75 price target are under review pending the company's earnings call.
PCG PG&E
$8.33

0.55 (7.07%)

10/01/19
LEHM
10/01/19
NO CHANGE
Target $10
LEHM
Equal Weight
PG&E price target lowered to $10 from $14 at Barclays
Barclays analyst Eric Beaumont lowered his price target for PG&E to $10 from $14 after updating his valuation methodology to reflect the recently announced settlements and align more closely with the company's $14B equity rights framework. To reflect "numerous unpredictable and material variables" for the outstanding common equity, the analyst reiterates an Equal Weight rating on PG&E. However, he sees the rights offering as being attractive to current holders, assuming the termination clauses as outlined, and believes the framework "provides a path to how an upside scenario may play out."
09/18/19
SBSH
09/18/19
NO CHANGE
Target $81
SBSH
Buy
Citi ups Edison International price target to $81, says wildfire risk priced in
Citi analyst Praful Mehta reiterated a Buy rating on Edison International (EIX) and raised his price target on the stock to $81 from $78, citing his view that the shares are undervalued given the company's strong growth, good safety and operational practices and strong management even with a relatively conservative approach on valuing the company's wildfire risk. California peer PG&E (PCG) is making good progress towards a June 2020 exit from bankruptcy, though if it does not exit in time Edison does have increased risk since the size of the wildfire fund for the 2020 season will shrink significantly, Mehta tells investors.
10/10/19
MSCO
10/10/19
NO CHANGE
Target $16
MSCO
Equal Weight
PG&E ruling raises uncertainty in bankruptcy process, says Morgan Stanley
Morgan Stanley analyst Stephen Byrd said that Judge Dennis Montali's decision to terminate PG&E's exclusive right to advance a plan of reorganization increases the uncertainty in the bankruptcy process, noting that the competing plan advanced by creditors would leave "very little equity value." The analyst, who believes PG&E's ability to negotiate with the victims groups and build support for its own plan will be a key driver of the stock from here, keeps an Equal Weight rating and $16 price target on the shares.
10/11/19
SBSH
10/11/19
DOWNGRADE
Target $5
SBSH
Sell
PG&E downgraded to Sell from Neutral at Citi
Citi analyst Praful Mehta downgraded PG&E to Sell from Neutral with a price target of $5, down from $12. The stock closed Thursday down 29%, or $3.19, to $7.79. After Judge Montali terminated PG&E's exclusive right to advance a plan of reorganization, Mehta sees a 75% chance of the stock going to zero. PG&E's goal of a tough negotiation stance with the tort claims committee backfired, says the analyst. He believes the company will now likely push for claim estimation given its limited ability to get into bidding war to settle with the TCC. Mehta assigns a 25% probability of PG&E getting its plan selected, a rights offering at $20 per share.
CGC Canopy Growth
$20.67

0.245 (1.20%)

10/11/19
JEFF
10/11/19
DOWNGRADE
Target $18.8
JEFF
Underperform
Jefferies downgrades Canopy to Underperform, calls most expensive in cannabis
Jefferies analyst Owen Bennett downgraded Canopy Growth to Underperform from Hold with a price target of $18.80. The stock closed Thursday down $2.37 to $20.42. Despite the recent selloff in shares, Canopy is the most expensive name across the cannabis space, Bennett tells investors in a research note. The analyst, who believes the company still has "material potential" long-term, says signs of share pressures in Canada, weak margin and profit performance in the near term, a lack of material catalysts, and "question marks over how successful beverages will be" warrant a downgrade to Underperform.
10/11/19
JEFF
10/11/19
DOWNGRADE
JEFF
Underperform
Canopy Growth downgraded to Underperform from Hold at Jefferies
Jefferies analyst Ryan Tomkins downgraded Canopy Growth to Underperform from Hold with a C$25 price target.
10/10/19
STFL
10/10/19
NO CHANGE
STFL
Hexo miss further damages cannabis industry credibility, says Stifel
Hexo (HEXO) this morning provided a preliminary update for its fiscal Q4 with revenue coming in below the consensus estimate and well below the "double" offered by management mid-quarter during the Q3 earnings call, Stifel analyst Andrew Carter tells investors in a research note. The preannouncement is "another headline damaging" the cannabis industry's credibility, Carter tells investors in a research note. For companies facing "significant financing risk," the analyst believes a "real segregation of assets will occur." Some companies will face significant dilution due to onerous financing terms while others will simply be unable to access capital, predicts the analyst. Carter thinks the macro environment will continue to be difficult and that the capital positions of Canopy Growth (CGC) and Cronos Group (CRON) are "clear competitive advantages." Those two have the ability to continue executing their business plans while capitalizing on the sector weakness, which "will only intensify from here," says Carter. Other names in the cannabis space include Aphria (APHA), Aurora Cannabis (ACB), CV Sciences (CVSI), CannTrust Holdings (CNTTF), General Cannabis (CANN), India Globalization Capital (IGC), Tilray (TLRY) and Zynerba (ZYNE). Shares of Hexo are down 24%, or 90c, to $2.78 in early trading.
10/11/19
JEFF
10/11/19
UPGRADE
JEFF
Hold
Jefferies upgrades Hexo to Hold, says pressures now understood
Jefferies analyst Owen Bennett upgraded Hexo (HEXO) to Hold from Underperform with a price target of $2.90. The pressures facing the company are now better understood following its weaker than expected outlook, Bennett tells investors in a research note. The analyst this morning also downgraded Canopy Growth (CGC) to Underperform from Hold. His top picks Cannabis are Aurora Cannabis (ACB), Aphria (APHA) and Green Organic Dutchman (TGODF).

TODAY'S FREE FLY STORIES

I

Intelsat

$26.09

1.09 (4.36%)

06:05
10/16/19
10/16
06:05
10/16/19
06:05
Hot Stocks
Intelsat and Marlink extend partnership for maritime broadband services »

Intelsat and Marlink have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOMX

Foamix

$3.00

0.145 (5.09%)

06:03
10/16/19
10/16
06:03
10/16/19
06:03
Recommendations
Foamix analyst commentary  »

Barclays likes Foamix…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 20

    Oct

TWTR

Twitter

$40.26

0.5 (1.26%)

06:03
10/16/19
10/16
06:03
10/16/19
06:03
Hot Stocks
Twitter clarifies when it will enforce rules against world leaders »

Twitter said in a blog…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

MOH

Molina Healthcare

$117.37

4.885 (4.34%)

06:02
10/16/19
10/16
06:02
10/16/19
06:02
Hot Stocks
Molina Healthcare to acquire certain assets of YourCare Health Plan for $40M »

Molina Healthcare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

FBM

Foundation Building Materials

$17.55

0.11 (0.63%)

06:01
10/16/19
10/16
06:01
10/16/19
06:01
Upgrade
Foundation Building Materials rating change  »

Foundation Building…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBSH

Commerce Bancshares

$60.24

0.87 (1.47%)

06:00
10/16/19
10/16
06:00
10/16/19
06:00
Earnings
Commerce Bancshares reports Q3 EPS 98c, consensus 92c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APDN

Applied DNA Sciences

$0.18

-0.0264 (-12.57%)

05:59
10/16/19
10/16
05:59
10/16/19
05:59
Hot Stocks
Applied DNA Sciences enters partnership with Molecular Isotope Technologies »

Applied DNA Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

GOOG

Alphabet

$1,243.53

25.3 (2.08%)

, GOOGL

Alphabet Class A

$1,242.51

24.9 (2.05%)

05:59
10/16/19
10/16
05:59
10/16/19
05:59
Periodicals
Google staff fighting over decision to ban protest video game app, Vox reports »

Google employees are…

GOOG

Alphabet

$1,243.53

25.3 (2.08%)

GOOGL

Alphabet Class A

$1,242.51

24.9 (2.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 27

    Oct

  • 28

    Oct

  • 28

    Oct

  • 29

    Oct

JNJ

Johnson & Johnson

$132.84

2.17 (1.66%)

05:59
10/16/19
10/16
05:59
10/16/19
05:59
Upgrade
Johnson & Johnson rating change  »

Johnson & Johnson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLND

Millendo Therapeutics

$7.12

0.04 (0.56%)

05:55
10/16/19
10/16
05:55
10/16/19
05:55
Conference/Events
Millendo Therapeutics management to meet with SVB Leerink »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

UCBJF

UCB

$0.00

(0.00%)

05:52
10/16/19
10/16
05:52
10/16/19
05:52
Upgrade
UCB rating change  »

UCB upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IFNNY

Infineon

$0.00

(0.00%)

05:51
10/16/19
10/16
05:51
10/16/19
05:51
Downgrade
Infineon rating change  »

Infineon downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

C

Citi

$71.25

0.97 (1.38%)

, TATYY

Tate & Lyle

$0.00

(0.00%)

05:49
10/16/19
10/16
05:49
10/16/19
05:49
Hot Stocks
Citi appointed as successor depositary bank for Tate & Lyle ADR programme »

Citi (C), acting through…

C

Citi

$71.25

0.97 (1.38%)

TATYY

Tate & Lyle

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 12

    Nov

  • 14

    Jan

CBT

Cabot

$43.89

0.17 (0.39%)

05:48
10/16/19
10/16
05:48
10/16/19
05:48
Downgrade
Cabot rating change  »

Cabot downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

AYI

Acuity Brands

$124.81

2.81 (2.30%)

05:47
10/16/19
10/16
05:47
10/16/19
05:47
Downgrade
Acuity Brands rating change  »

Acuity Brands downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOW

ServiceNow

$274.60

5.45 (2.02%)

05:45
10/16/19
10/16
05:45
10/16/19
05:45
Downgrade
ServiceNow rating change  »

ServiceNow downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 12

    Dec

ADBE

Adobe

$279.40

1.61 (0.58%)

05:44
10/16/19
10/16
05:44
10/16/19
05:44
Downgrade
Adobe rating change  »

Adobe downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 27

    Oct

  • 29

    Oct

  • 04

    Nov

FMC

FMC Corporation

$83.06

0.6 (0.73%)

05:32
10/16/19
10/16
05:32
10/16/19
05:32
Upgrade
FMC Corporation rating change  »

FMC Corporation upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

SUBCY

Subsea 7

$0.00

(0.00%)

05:32
10/16/19
10/16
05:32
10/16/19
05:32
Downgrade
Subsea 7 rating change  »

Subsea 7 downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

RBS

RBS

$5.82

0.38 (6.99%)

05:28
10/16/19
10/16
05:28
10/16/19
05:28
Upgrade
RBS rating change  »

RBS upgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 24

    Oct

INOV

Inovalon

$15.04

0.2 (1.35%)

05:27
10/16/19
10/16
05:27
10/16/19
05:27
Initiation
Inovalon initiated  »

Inovalon initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UTX

United Technologies

$136.17

0.26 (0.19%)

05:26
10/16/19
10/16
05:26
10/16/19
05:26
Hot Stocks
Collins Aerospace, Lufthansa sign A380 main landing gear MRO agreement »

Collins Aerospace…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

HOLX

Hologic

$49.44

0.94 (1.94%)

05:25
10/16/19
10/16
05:25
10/16/19
05:25
Recommendations
Hologic analyst commentary  »

Hologic shares can keep…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

GLPG

Galapagos

$162.62

6.33 (4.05%)

05:24
10/16/19
10/16
05:24
10/16/19
05:24
Hot Stocks
Galapagos enters drug discovery research collaboration with HitGen »

HitGen announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

EPAY

Bottomline Technologies

$40.79

0.34 (0.84%)

05:21
10/16/19
10/16
05:21
10/16/19
05:21
Hot Stocks
Bottomline Technologies, Currencycloud partnership selected by Hargenant Group »

Bottomline Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 11

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.